What's hot
View all perspectives
What's Hot
RheumNow Rheumatology Roundup: Drs. Kavanaugh and Cush
Rheumatology Roundup! Drs. Cush and Kavanaugh convene for their annual impromptu review of some of the best and more interesting abstracts presented at ACR 2021.
Watch video →
TNF Inhibitor Panel Discussion: ACR21 Annual Meeting
RheumNow TNFi faculty convened to discuss several TNFi-related abstracts presented at ACR 21. Panelists: Drs. Aurelie Najm, Janet Pope, David Liew, Eric Dein and Swetha Alexander.
Watch video →
Spondyloarthritis Panel Discussion: ACR21 Meeting
Panelists: Drs. Antoni Chan, Robert Chao, Rachel Tate, Sheila Reyes and Akhil Sood. Abstracts discussed include #0562, #1919, #0907, #0364 and #0919
Watch video →
Might Tofacitinib Reduce Malignancy Risk with Patients with RA? Dr. Jonathan Kay
Dr. Kay discusses abstract 1940 and abstract 980 presented at the ACR21 annual meeting.
Watch video →
Diagnosing (Bad) VEXAS: The Experts Speak Drs. Beck and Ferrada
Dr. Cush discusses Dr. Marcela Ferrada and Dr. David Beck to discuss VEXAS syndrome and abstract 1426, which was presented at the ACR21 annual meeting.
Watch video →
Pediatric Psoriatic Arthritis: Dr. Eric Ruderman
Dr. Ruderman discusses abstracts #1424 presented at the ACR21 annual meeting.
Watch video →
Urine Proteome Advances: What Do They Mean? Dr. Michelle Petri
Dr. Petri reviews abstracts #1422 and #1936, presented at the ACR21 annual meeting.
Watch video →
ACR21 Day 3 Recap: Polypharmacy, New Lupus Drugs, VEXAS, Safety Data
Blurb: Drs. Jack Cush and the RheumNow Faculty Drs. Akhil Sood, Antoni Chan, Olga Petryna and Eric Dein, discuss highlights from Day 3 (Monday) at the ACR21 annual meeting. Abstracts include #1367, #1044, #1444, #1083 and more.
Watch video →
Cardiovascular Disease for TNFi vs JAKi: Dr Jon Giles
Dr. Giles discusses abstracts #0831and #0958 presented at the ACR21 annual meeting.
Watch video →
Predictors of TNF Response with Drs. Pope, Dein and Liew
Drs. Janet Pope, David Liew and Eric Dein discuss TNF data presented at the ACR21 annual meeting, including abstracts #1251, #1442, #1448.
Watch video →
Caring for the Older Patient with Rheumatic Disease: Drs. Makris, Yung and Dao
Drs. Kathryn Dao, Una Makris and Raymond Yung discuss the field of geriatric rheumatology and caring for the older patient with rheumatic disease.
Watch video →
Autoinflammatory: PAH in AOSD, VEXAS, JAKi in Still's, Role of labs in infections vs. flares
Drs. Jack Cush, Yuz Yusof, Bella Mehta, Olga Petryna and Rachel Tate review autoinflammatory data presented at the ACR21 annual meeting, including abstracts #1100, #1062, #1426, #0252, #0195, and #1083.
Watch video →
FDA Session Review: Dr. Arthur Kavanaugh
Dr. Kavanaugh discussed the FDA session presented at the ACR21 annual meeting, including safety data and new approvals and indications in several rheumatic diseases, including lupus, ANCA-associated vasculitis, lupus nephritis and more.
Watch video →
The Respiratory Tract and RA with Drs. Sparks, McDermott and Kronzer
Drs. Jeffrey Sparks, Greg McDermott and Vanessa Kronzer discuss work in the area of respiratory disease in RA, mucosal paradigm, RA-ILD, bronchiectasis, as well as their experience as virtual attendees at the ACR21 annual meeting.
Watch video →
Pulmonary Hypertension in Adult Onset Still's Disease: Dr. Jack Cush
Dr. Cush reviews poster #1100 presented at the ACR21 annual meeting.
Watch video →
Data on Existing SLE Medications, Patient Centered Outcomes, and Exercise: Dr. Michelle Petri
Dr. Petri discusses data on existing SLE medications, patient-centered outcomes and the importance of exercise, presented Monday at the ACR21 annual meeting.
Watch video →
ACR21 Day 2 Recap: CV Risk, Tapering in SpA, Microbiome in PsA, Vit D
Drs. Jack Cush and the RheumNow Faculty Drs. David Liew, Swetha Ann Alexander, Meral El Ramahi, Mrinalini Dey and Robert Chao, discuss highlights from Day 2 (Sunday) at the ACR21 Virtual meeting.
Watch video →
Dr. John Cush RheumNow
4 years ago
Watch: Scary Steroids
QD Clinic is sponsored by https://t.co/V10S4oVFsv's coverage of #ACR21
https://t.co/jnruS0m3Gr https://t.co/REMKWoR6DQ
Dr. John Cush RheumNow
4 years ago
#ACR21 is just days away and we want to see your best images of learning virtually, missing a meeting in San Francisco, wellness, or break time activities.
Tweet your pic and make sure to include #RheumPix and #ACR21 and we’ll share our favorites. https://t.co/DTyOKrlG7J
Dr. John Cush RheumNow
4 years ago
Infection Rates in Psoriatic Arthritis Patients on Biologics Have Decreased #ACR21
https://t.co/dWrlIBHya7 https://t.co/U9hXcXUrI5
The pharmaceutical companies will feature the results of their pivotal clinical trials and data analyses at ACR Convergence 2021. Below is a listing of some of their best studies for you to review and look for in the meeting. Often these become the pivotal studies for regulatory approval and the annual congresses are their first look.
Aurinia
Dr. John Cush RheumNow
4 years ago
NOR-DRUM Study: TNF Inhibitor Therapeutic Drug Monitoring is Effective
https://t.co/RPS6OiXsx2
#ACR21 https://t.co/uMv5LNq3Sh
Dr. John Cush RheumNow
4 years ago
Sign up today to receive #ACR21 news and select topic emails throughout the conference. #RheumNow
https://t.co/riyAnrRHhX https://t.co/IEjvmn7glF
Post-pandemic structured surveys and interviews with rheumatology patients suggests they may prefer for face-to-face consultations, as telehealth visits run the risk of diagnostic inaccuracies and safety concerns.
Researchers surveyed a total of 1,340 (UK) patients and 111 clinicians n = 111 and interviewed 31 patients and 29 clinicians between April and July 2021.
Dr. John Cush RheumNow
4 years ago
Rituximab Patients May Benefit from Third COVID-19 Vaccine Dose
This abstract will be presented at 10:45am EST, Tuesday, November 9, 2021 during the Late-Breaking Abstracts session (L16 - L21). #ACR21
https://t.co/A1nAL8OnCu https://t.co/lsSyZmjfuF
Janet Pope Janetbirdope
4 years ago
#ClinicalPearl Distal fingers in #Scleroderma lose pulp. In this patient #calcinosis (chronic) caused the nail/bed to expand! @RheumNow @CRASCRRheum https://t.co/bj4cxP7q6J
Dr. John Cush RheumNow
4 years ago
I like this. Downloaded and read. Great for patients too! https://t.co/B081u0ijjU
Dr. John Cush RheumNow
4 years ago
Survey of 10,234 Dannish Primary Care pts (w/ LBP, hip or knee #OA)to Dx self reported Lumbar Spinal Stenosis (LSS) based on 11 Sxs. LSS Sxs were more in LBP (11–71%) than hip (11–50%) or knee OA (8–40%). Overall LSS seen <10% cohorts https://t.co/v9LO09IZla
Dr. John Cush RheumNow
4 years ago
But baricitinib inhibits endocytosis of the virus and thus should be antiviral early in the disease. I believe the paradox is based on who gets bari, mostly those with poorly controlled disease https://t.co/euOthMLDt3
Dr. John Cush RheumNow
4 years ago
1119 thoracic aortic surgeries - 3.7% dx as inflammatory aortitis (66% CIA, 27% GCA, 5% TAK) (20% given steroids). Aortitis were more female, older, more HTN w/ more immunosuppressives, but no diff in 30d mortality (7.3 vs 6.5%) https://t.co/94VBaRAry5
Rohit Aggarwal docrota
4 years ago
Happy Diwali to all my Twitter friends. May this festival of light glow your life with knowledge, happiness and prosperity. I also feel for all those who lost their loved one this year to Covid and may Diwali brings peace to you as well. https://t.co/xRGnuxz068
Dr. John Cush RheumNow
4 years ago
CRESPA trial pts (Golimumab in monoRx peripheral SpA) offered change to MTX. 25/60 pSpA entered the step-down to MTX, but 21/25 flared & 4 (16%) stayed in remission (others restarted GOL). MTX cant maintain GOL remission in pSpA https://t.co/zGg3UqoDqp
Podcasts
Giant Cell Arteritis and Polymyalgia Rheumatic Wrapup: Drs. Calabrese, Liew, Conway and Mackie00:20:18 -
Reproductive Health in Rheumatic Diseases: Drs. Bermas, Buyon and Dao
00:20:26 -
The Expert Gout Panel with Drs. Neogi, Saag, Pillinger, Cush and O'Dell
00:35:26
Poster Hall